Showing results (631-640 of 642) with videos related to
Sort By:
Pageof 65
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.Immunity|May 22, 2021
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targetsHaley L Dugan, Christopher T Stamper, Lei Li, et al.Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.Biorxiv : the Preprint Server for Biology|June 9, 2022
A Multitrait Locus Regulates Sarbecovirus PathogenesisAlexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023Therese B Bevers, Bethany L Niell, Jennifer L Baker, et al.Nature Neuroscience|March 25, 2015
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementiaAxel Freischmidt, Thomas Wieland, Benjamin Richter, et al.Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.Mbio|July 21, 2022
A Multitrait Locus Regulates Sarbecovirus PathogenesisAlexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.The Lancet. Respiratory Medicine|May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityMarcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.Pageof 65